Alumis, Inc. (ALMS)
5.60
-0.53
(-8.65%)
USD |
NASDAQ |
Nov 13, 16:00
5.55
-0.05
(-0.89%)
After-Hours: 19:59
Alumis Enterprise Value : 330.18M for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 330.18M |
| November 12, 2026 | 398.91M |
| November 11, 2026 | 462.45M |
| November 10, 2026 | 433.92M |
| November 09, 2026 | 453.38M |
| November 06, 2026 | 385.94M |
| November 05, 2026 | 362.60M |
| November 04, 2026 | 453.38M |
| November 03, 2026 | 446.89M |
| November 02, 2026 | 431.33M |
| October 30, 2026 | 476.72M |
| October 29, 2026 | 497.47M |
| October 28, 2026 | 528.59M |
| October 27, 2026 | 465.05M |
| October 26, 2026 | 448.19M |
| October 23, 2026 | 483.20M |
| October 22, 2026 | 488.39M |
| October 21, 2026 | 487.09M |
| October 20, 2026 | 472.83M |
| October 19, 2026 | 426.14M |
| October 16, 2026 | 397.61M |
| October 15, 2026 | 422.25M |
| October 14, 2026 | 389.83M |
| October 13, 2026 | 454.67M |
| October 12, 2026 | 519.51M |
| Date | Value |
|---|---|
| October 09, 2026 | 532.48M |
| October 08, 2026 | 507.84M |
| October 07, 2026 | 481.90M |
| October 06, 2026 | 502.65M |
| October 05, 2026 | 490.98M |
| October 02, 2026 | 492.28M |
| October 01, 2026 | 538.96M |
| September 30, 2026 | 562.31M |
| September 29, 2026 | 470.94M |
| September 28, 2026 | 454.23M |
| September 25, 2026 | 446.52M |
| September 24, 2026 | 470.94M |
| September 23, 2026 | 490.21M |
| September 22, 2026 | 576.31M |
| September 21, 2026 | 549.33M |
| September 18, 2026 | 532.62M |
| September 17, 2026 | 539.05M |
| September 16, 2026 | 554.47M |
| September 15, 2026 | 613.58M |
| September 14, 2026 | 718.95M |
| September 11, 2026 | 713.81M |
| September 10, 2026 | 806.34M |
| September 09, 2026 | 793.49M |
| September 08, 2026 | 893.72M |
| September 04, 2026 | 960.54M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Johnson & Johnson | 715.26B |
| BioAge Labs, Inc. | -25.88M |
| ANI Pharmaceuticals, Inc. | 1.807B |
| Corcept Therapeutics, Inc. | 7.615B |
| Veru, Inc. | 12.53M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -94.88M |
| Revenue (Quarterly) | 1.907M |
| Total Expenses (Quarterly) | 96.79M |
| EPS Diluted (Quarterly) | -0.7338 |
| Gross Profit Margin (Quarterly) | 53.70% |
| Profit Margin (Quarterly) | -4.98K% |
| Earnings Yield | -62.13% |
| Normalized Earnings Yield | -56.62 |